Prekopp G, Rosdy E
Orv Hetil. 1993 Dec 12;134(50):2757-60.
Since 1988 27 patients with bladder cancer - in the T1, G1, G2 stage - have been treated by intra-cavitally applied BCG (Pasteur). The follow-up period was 12-62 months. There was no relapse in 18 cases (66%) in 4 cases (16%) increase the average relapse rate, in 5 cases the treatment was unsuccessful. These results suggest that the treatment is effective, affordable and occur few complications.
自1988年以来，27例处于T1、G1、G2期的膀胱癌患者接受了膀胱腔内灌注卡介苗（巴斯德株）治疗。随访期为12至62个月。18例（66%）无复发，4例（16%）平均复发率增加，5例治疗失败。这些结果表明该治疗有效、经济且并发症少。
